Bristol Myers Squibb reports death in Phase 1 autoimmune CAR-T multiple sclerosis trial
Bristol Myers Squibb reported that a patient died in an early Phase 1 trial of its investigational CAR-T therapy for multiple sclerosis. The patient had motor symptoms that did not respond to standard autoimmune treatments and was later given a potent…
